ARTICLE | Clinical News
Amlexanox: To begin Phase III trial
April 26, 1993 7:00 AM UTC
Chemex Pharmaceuticals Inc. (CHMX) Product: Amlexanox, an anti-allergic agent Indication: Canker sores Status: To begin Phase III trial Note: Product is a joint venture with Block Drug ...